I agree and add this. If R-It shows good results, Europe will become the largest market for Vascepa. Which doctor would risk not prescribing a life saving drug?
No drug "sells itself" - else BP wouldn't spend billions of dollars and such a huge % of their total budget on TV advertising. Even if R-IT results grabs headlines on the WSJ front page, many (most?) people won't be aware of V, and if they hear about it they'll quickly forget - we now have an ADHD society because of smart phones and Facebook.
Market Data 
Markets 
AI
